Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection

被引:64
作者
Scheijen, Jean L. J. M. [2 ]
van de Waarenburg, Marjo P. H. [2 ]
Stehomer, Coen D. A. [1 ,2 ]
Schalkwijk, Casper G. [1 ,2 ]
机构
[1] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
[2] Maastricht Univ, Lab Metab & Vasc Med, Dept Internal Med, Maastricht, Netherlands
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2009年 / 877卷 / 07期
关键词
HPLC; Fluorescence; Pentosidine; Peritoneal dialysis; GLYCATION END-PRODUCTS; TANDEM MASS-SPECTROMETRY; RENAL-DISEASE PATIENTS; PERITONEAL-DIALYSIS; CROSS-LINKS; EXTRACELLULAR PROTEINS; METHYLGLYOXAL LEVELS; UREMIC PATIENTS; HPLC METHOD; SERUM;
D O I
10.1016/j.jchromb.2009.01.022
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
A rapid and sensitive single-column high-performance liquid chromatography method and application for the detection of protein bound pentosidine is described. Pentosidine. a cross-link between arginine and lysine, is a well-characterized advanced glycation endproduct. In order to detect protein-bound pentosidine, plasma proteins were hydrolysed in 6 N HCl. Detection of pentosidine is done based on its own fluorescence characteristics using fluorimetric detection (E-x = 325 nm, E-m = 385 nm). Separation is done, with a run-to-run time of 30 min, on a C-18 Allspehere ODS-ll column with a citric acid acetonitrile buffer. This detection enables sensitive and specific determination of protein bound pentosidine in plasma with a detection limit of 2.2 nmol/l or 0.02 pmol/mg protein (signal-to-noise: 6). The intra-assay coefficient variation is 6.5% at a plasma pentosidine concentration of 0.47 pmol/mg protein and 2.0% at a concentration of 1.27 pmol/mg protein. The inter-assay coefficient variation is 3.1% at a plasma pentosidine concentration of 0.43 pmol/mg protein and 1.6% at a concentration of 1.40 pmol/mg protein. Linearity is tested in 4 different plasma samples and showed linearity (0-200 nmol/l, r(2) > 0.99). Recovery of pentosidine in 4 different plasma samples at different concentration levels is 102 +/- 10% (mean +/- SD). Using this method protein bound pentosidine concentration is investigated in healthy controls (n = 24, age 67 9 years) and patients with end stage renal disease (n = 24, age 65 10 years). Higher plasma concentrations of protein bound pentosidine are measured in the patient group as compared with the control group 3.05 (2.03-3.92) pmol/mg protein and 0.21 (0.19-0.33) pmol/mg protein. respectively (median (interquartile range), p < 0.00001). These results are consistent with previously reported results. (c) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:610 / 614
页数:5
相关论文
共 35 条
[1]
Agalou S, 2003, BIOCHEM SOC T, V31, P1394
[2]
Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence [J].
Ahmed, N ;
Thornalley, PJ .
BIOCHEMICAL JOURNAL, 2002, 364 (01) :15-24
[3]
Ahmed N, 2003, BIOCHEM SOC T, V31, P1417
[4]
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes [J].
Basta, G ;
Schmidt, AM ;
De Caterina, R .
CARDIOVASCULAR RESEARCH, 2004, 63 (04) :582-592
[5]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]
Direct detection of crosslinks of collagen and elastin in the hydrolysates of human yellow ligament using single-column high performance liquid chromatography [J].
Chen, JR ;
Takahashi, M ;
Kushida, K ;
Suzuki, M ;
Suzuki, K ;
Horiuchi, K ;
Nagano, A .
ANALYTICAL BIOCHEMISTRY, 2000, 278 (02) :99-105
[7]
DYER DG, 1991, J BIOL CHEM, V266, P11654
[8]
Analytical strategy for the assessment of the protein glycation status in uremic patients by high-performance liquid chromatography [J].
Floridi, A ;
Trizza, V ;
Paolotti, P ;
Lucarelli, C .
JOURNAL OF CHROMATOGRAPHY A, 1999, 846 (1-2) :65-71
[9]
Early and advanced glycosylation end products - Kinetics of formation and clearance in peritoneal dialysis [J].
Friedlander, MA ;
Wu, YC ;
Elgawish, A ;
Monnier, VM .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :728-735
[10]
Advanced glycation end products - Sparking the development of diabetic vascular injury [J].
Goldin, Alison ;
Beckman, Joshua A. ;
Schmidt, Ann Marie ;
Creager, Mark A. .
CIRCULATION, 2006, 114 (06) :597-605